Urgent

Histoplasmosis & endemic mycoses

Endemic fungi · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Endemic dimorphic fungi (Histoplasma, Blastomyces, Coccidioides, Talaromyces) cause pulmonary and, in the immunosuppressed, disseminated disease after travel/residence in endemic areas. Severity dictates amphotericin induction versus oral azole.

Red flags

  • Respiratory failure or ARDS
  • Disseminated disease with sepsis in HIV
  • CNS involvement (meningitis)
  • Adrenal insufficiency (histoplasmosis)
  • Rapid deterioration

Assessment

Differential diagnosis

  • Tuberculosis
  • Sarcoidosis
  • Community-acquired pneumonia
  • Malignancy/lymphoma
  • Other opportunistic infection in HIV

Investigations

  • Travel/residence history for endemic exposure
  • Fungal culture and histopathology of tissue/respiratory samples
  • Histoplasma urine/serum antigen (and other antigen tests)
  • CT chest; imaging of disseminated sites
  • HIV test and CD4
  • Serology where appropriate (e.g. coccidioidomycosis)

Management

  • Take a detailed travel/residence and exposure history
  • Obtain antigen testing, cultures and histology from affected sites
  • Assess severity and immune status (disseminated disease in HIV/immunosuppressed)
  • Treat mild, self-limited pulmonary disease with observation or oral azole
  • Start liposomal amphotericin B induction for severe/disseminated disease
  • Step down to oral itraconazole (histoplasmosis/blastomycosis) after improvement
  • Use fluconazole for coccidioidal meningitis (lifelong) per type
  • Monitor azole levels (itraconazole) and liver function
  • In HIV, start ART with attention to IRIS
  • Give prolonged therapy and secondary prophylaxis where immunosuppression persists
  • Watch for relapse with antigen monitoring
  • Specialist ID follow-up

Drugs & doses

Liposomal amphotericin B 3 mg/kg IV daily (5 mg/kg for CNS) for severe/disseminated induction
Itraconazole 200 mg PO three times daily for 3 days then twice daily (histoplasmosis/blastomycosis)
Fluconazole 400-800 mg PO daily (coccidioidomycosis; lifelong for meningitis)
Itraconazole maintenance with therapeutic drug monitoring

Disposition

Admit for severe/disseminated disease; outpatient oral azole for mild; ID follow-up.

Complications & pitfalls

  • Disseminated multi-organ disease
  • Chronic cavitary pulmonary disease
  • CNS infection and hydrocephalus
  • Adrenal insufficiency
  • Relapse / IRIS in HIV

Exam pearls

  • Geography is key - ask where the patient has lived/travelled
  • Urine Histoplasma antigen is useful for rapid diagnosis of disseminated disease
  • Itraconazole requires therapeutic drug monitoring; absorption is variable
  • Coccidioidal meningitis needs lifelong fluconazole
  • Consider in HIV patients with unexplained disseminated illness from endemic regions

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.